{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:08:55Z","timestamp":1776200935717,"version":"3.50.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patient surges beyond hospital capacity during the initial phase of the COVID-19 pandemic emphasized a need for clinical laboratories to prepare test processes to support future patient care. The objective of this study was to determine if current instrumentation in local hospital laboratories can accommodate the anticipated workload from COVID-19 infected patients in hospitals and a proposed field hospital in addition to testing for non-infected patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Simulation models predicted instrument throughput and turn-around-time for chemistry, ion-selective-electrode, and immunoassay tests using vendor-developed software with different workload scenarios. The expanded workload included tests from anticipated COVID patients in 2 local hospitals and a proposed field hospital with a COVID-specific test menu in addition to the pre-pandemic workload.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Instrumentation throughput and turn-around time at each site was predicted. With additional COVID-patient beds in each hospital, the maximum throughput was approached with no impact on turnaround time. Addition of the field hospital workload led to significantly increased test turnaround times at each site.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Simulation models depicted the analytic capacity and turn-around times for laboratory tests at each site and identified the laboratory best suited for field hospital laboratory support during the pandemic.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfaa231","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T20:10:21Z","timestamp":1606421421000},"page":"451-462","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 Pandemic Planning: Simulation Models to Predict Biochemistry Test Capacity for\u00a0Patient Surges"],"prefix":"10.1093","volume":"6","author":[{"given":"Martha E","family":"Lyon","sequence":"first","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bajkov","sequence":"additional","affiliation":[{"name":"Roche Diagnostics Canada, Laval, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Haugrud","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry D","family":"Kyle","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W","family":"Lyon","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Division of Clinical Biochemistry, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"2021030606031321700_jfaa231-B1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1197\/j.aem.2006.06.041","article-title":"Understanding surge capacity: essential elements","volume":"13","author":"Barbisch","year":"2006","journal-title":"Acad. Emerg. Med"},{"key":"2021030606031321700_jfaa231-B2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/milq.12003","article-title":"Health systems \u2018surge capacity\u2019: state of the art and priorities for future research","volume":"91","author":"Watson","year":"2013","journal-title":"Milbank Q"},{"key":"2021030606031321700_jfaa231-B3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3201\/eid1709.102012","article-title":"Epidemiologic modeling with FluSurge for pandemic (H1N1) 2009 outbreak, Queensland, Australia","volume":"17","author":"Baker","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2021030606031321700_jfaa231-B4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0950268810002220","article-title":"Health service resource needs for pandemic influenza in developing countries: a linked transmission dynamics, interventions and resource demand model","volume":"139","author":"Krumkamp","year":"2011","journal-title":"Epidemiol Infect"},{"key":"2021030606031321700_jfaa231-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/183747","article-title":"An innovative approach to functionality testing of analyzers in the clinical laboratory","volume":"2008","author":"Stockmann","year":"2008","journal-title":"J Autom Methods Manag Chem"},{"key":"2021030606031321700_jfaa231-B6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/2211068212472183","article-title":"Cobas 8000 Modular Analyzer Series Evaluated under Routine-like Conditions at 14 Sites in Australia, Europe, and the United States","volume":"18","author":"von Eckardstein","year":"2013","journal-title":"J Lab Autom"},{"key":"2021030606031321700_jfaa231-B7"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jalm\/advance-article-pdf\/doi\/10.1093\/jalm\/jfaa231\/35923705\/jfaa231.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/2\/451\/36419288\/jfaa231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jalm\/article-pdf\/6\/2\/451\/36419288\/jfaa231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T06:07:57Z","timestamp":1615010877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/6\/2\/451\/6008695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,28]]},"published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaa231","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,11,28]]}}}